TRiBE: TB PCR in BAL and EBUS-TBNA

  • Research type

    Research Study

  • Full title

    Xpert MTB/RIF Ultra assay for the detection of Mycobacterium tuberculosis (MTB) in bronchoalveolar lavage (BAL) for pulmonary TB and endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) samples for mediastinal TB.

  • IRAS ID

    266798

  • Contact name

    Onn Min Kon

  • Contact email

    onn.kon@nhs.net

  • Sponsor organisation

    Imperial College London and Imperial College Healthcare NHS Trust

  • Clinicaltrials.gov Identifier

    NCT04909385

  • Duration of Study in the UK

    0 years, 11 months, 15 days

  • Research summary

    This prospective observational multi-centre UK study will evaluate Xpert MTB/RIF Ultra for the detection of tuberculosis in bronchoalveolar lavage (BAL) samples for pulmonary TB and endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) samples for lymph node TB. The diagnostic accuracy of the test will be compared to other current conventional tests (smear, culture, cytology).

    The performance of Xpert Ultra will be assessed by calculating the sensitivity, specificity, positive predictive and negative predictive value. The turn-around time of all various methods of TB diagnosis will be measured, and the ensuing effect on treatment decisions assessed. Finally, we will analyse the ‘Trace’ readings from Xpert Ultra and describe the clinical characteristics of the patients with these readings.

  • REC name

    South East Scotland REC 01

  • REC reference

    20/SS/0089

  • Date of REC Opinion

    7 Oct 2020

  • REC opinion

    Further Information Favourable Opinion